Follow CGSP on Social Media

Listen to the CGSP Podcast

Seychelles President: No Link Between Chinese Vaccine Efficacy and Surging Infection Rate

by Eric Olander
Seychelles President Wavel Ramkalawan. Image via Seychelles News Agency.

Seychelles President Wavel Ramkalawan insisted there’s no link between a recent surge of COVID-19 infections and low efficacy rates of either the Chinese-made Sinopharm vaccine or the Covishield AstraZeneca jab imported from India.

Infection rates have doubled recently on the small Indian Ocean island state. This came as a surprise to many, given that Seychelles inoculated a higher percentage of its population than any country in the world. In an interview with the Seychelles News Agency late Monday, the president explained the recent uptick in infections and why the vaccines are not necessarily to blame:

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

OR

Already a subscriber? Log in Click Here to Learn More

You Might Like

China’s COVID-19 Vaccine Rollout Gains Momentum in Many Developing Regions

There’s been a flurry of activity on the Chinese vaccine distribution front. Over the weekend, a growing number of countries across the Global South are taking delivery of Chinese-made COVID-19 vaccines even before ...

The Seychelles Is the New Focal Point to Evaluate the Effectiveness of Chinese-Made Vaccines

A new wave of COVID-19 infections is sweeping across the tiny Indian Ocean island of The Seychelles. This wasn’t supposed to happen. With nearly 60% of its people vaccinated, The ...

As Infections Rise in Countries Previously Vaccinated With Chinese Jabs, Doubts Persist About Vaccine Efficacy

The effectiveness of Chinese-made vaccines is emerging as an enduring narrative in the U.S. media due in part to resurgent infection rates in countries that have relied heavily on Sinopharm and Sinovac jabs. ...

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

Subscribe